Uzm. Dr. Ozan Cemal İçaçan
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Arthritis, Rheumatoid 3 publicationsSource: OpenAlex / PubMed MeSHView publications
- Lung Diseases, Interstitial 2 publications
- Scleroderma, Systemic 2 publications
- Behcet Syndrome 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyRheumatologysaglik.gov.trFrom source
- InstitutionKanuni Sultan Süleyman Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workArthritis, RheumatoidExtracted from 3 publications · Model version —From source
- Publications29 publicationsORCID, Europe PMC, OpenAlexFrom source
- ORCID0000-0002-1054-5034ORCIDFrom source
- Last synchronised5 November 2026 08:56https://kanunieah.saglik.gov.tr/TR-1479041/doktorlarimiz.html#ozan-cemal-icacansaglik.gov.tr
Scientific work
Publications on Arthritis, Rheumatoid
-
Clinical Association of Pan-Immune-Inflammation Value with MEFV Mutation Burden and Amyloidosis in Adults with Familial Mediterranean Fever: A Retrospective Cohort Study
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15135058 PMID 42452521 Open-access full textSource: ORCID
-
Association of serum Wnt1-inducible signaling pathway protein 1 (WISP1) levels with osteoarthritis and obesity-related inflammation in obese adults
Scientific reports, 2026
DOI 10.1038/s41598-026-52502-x PMID 42103993 Open-access full textSource: Europe PMC
-
The Frequency and Effect of Scoliosis in Patients with Ankylosing Spondylitis
Indian Journal of Rheumatology, 2025
DOI 10.1177/09733698251314953 Open-access full textSource: OpenAlex
-
IL-1 Inhibitors in the Treatment of Familial Mediterranean Fever: Treatment Indications and Clinical Features in a Large Real-World Cohort
Journal of Clinical Medicine, 2024
DOI 10.3390/jcm13123375 PMID 38929904 3 citations (OpenAlex) Open-access full textSource: OpenAlex
-
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry
Clinical and Experimental Rheumatology, 2023
DOI 10.55563/clinexprheumatol/2h6ma1 PMID 37650346 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
Pulmonary involvement in antineutrophil cytoplasmic antibody-associated vasculitides: A single center experience from Turkey
International journal of rheumatic diseases, 2023
DOI 10.1111/1756-185x.14764 PMID 37287386 7 citations (Europe PMC) Open-access full textSource: Europe PMC
-
Dermatomyositis associated with thymoma: A case report and literature review.
PubMed, 2023
DOI 10.7417/ct.2023.2506 PMID 36920126 4 citations (OpenAlex) Source: OpenAlex
-
Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology
Clinical and Experimental Rheumatology, 2023
DOI 10.55563/clinexprheumatol/ce13vk PMID 37470234 Open-access full textSource: OpenAlex
-
Inverted grayscale in hand X-rays in patients with rheumatoid arthritis: A pilot study
Ulusal Romatoloji Dergisi, 2023
DOI 10.4274/raed.galenos.2023.80774 Open-access full textSource: OpenAlex
-
Palpable purpura: is it associated with vasculitis or not? A single-center experience
Clinical rheumatology, 2022
DOI 10.1007/s10067-022-06075-5 PMID 35076788 2 citations (Europe PMC) Source: Europe PMC